MAPT and frontotemporal dementia: For instance, FTD patients carrying the APOE4 genotype display earlier onset tau pathology, more severe neurodegeneration, and greater cognitive decline than non-APOE4 carriers, suggesting APOE may influence tau pathology independently of Aβ pathology.